Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituxan and BEAM with Autologous Stem Cell Transplant for Indolent Lymphoma
NCT00572013Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- May 1998
- Primary completion
- Jan 2001
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in lymphoma, sponsored by University of Nebraska. Started May 1998; status: completed.
02
Drugs
rituximab
03
Conditions
lymphoma
Beyond the preview
Go deeper on NCT00572013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00572013.